Holen Sie sich die Stockscreener-App
0.3138
17.77%
-0.0678
Schlusskurs vom Vortag:
$0.3816
Offen:
$0.3702
24-Stunden-Volumen:
4.12M
Relative Volume:
14.51
Marktkapitalisierung:
$31.65M
Einnahmen:
$30.31M
Nettoeinkommen (Verlust:
$-22.84M
KGV:
-0.6973
EPS:
-0.45
Netto-Cashflow:
$-22.61M
1W Leistung:
+0.00%
1M Leistung:
-5.62%
6M Leistung:
-72.23%
1J Leistung:
-69.83%
1-Tages-Spanne:
$0.3138
$0.40
1-Wochen-Bereich:
$0.3138
$0.40
52-Wochen-Spanne:
$0.252
$1.275
Enzo Biochem Inc Stock (ENZ) Company Profile
Firmenname
Enzo Biochem Inc
Sektor
Branche
Telefon
(516) 755-5500
Adresse
60 EXECUTIVE BLVD, FARMINGDALE, NY
Vergleichen Sie ENZ mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ENZ
Enzo Biochem Inc
|
0.3138 | 31.65M | 30.31M | -22.84M | -22.61M | -0.45 |
|
TMO
Thermo Fisher Scientific Inc
|
425.80 | 160.15B | 42.90B | 6.52B | 6.72B | 17.05 |
|
DHR
Danaher Corp
|
199.54 | 141.09B | 23.82B | 3.77B | 4.90B | 5.15 |
|
IDXX
Idexx Laboratories Inc
|
473.07 | 35.45B | 3.90B | 887.87M | 798.08M | 10.67 |
|
A
Agilent Technologies Inc
|
108.55 | 30.37B | 6.53B | 1.26B | 1.31B | 4.35 |
|
IQV
Iqvia Holdings Inc
|
154.01 | 26.50B | 15.41B | 1.37B | 2.11B | 7.50 |
Enzo Biochem Inc Stock (ENZ) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2011-10-18 | Bestätigt | Rodman & Renshaw | Mkt Outperform |
| 2009-09-23 | Eingeleitet | Rodman & Renshaw | Mkt Outperform |
| 2007-09-13 | Eingeleitet | Lazard Capital | Buy |
Enzo Biochem Inc Aktie (ENZ) Neueste Nachrichten
Enzo Biochem (NYSE:ENZ) Now Covered by Analysts at StockNews.com - Defense World
Deadline to claim up to $10K from Enzo Biochem data breach settlement - Fingerlakes1.com
Press Release Distribution & PR Platform - ACCESS Newswire
Enzo Biochem (NYSE:ENZ) Coverage Initiated at StockNews.com - Defense World
Recent Insider Activity Suggests Potential Gains for Enzo Biochem, Inc (ENZ) - knoxdaily.com
Enzo Biochem, Inc (ENZ)’s stock price range in the last year - uspostnews.com
Enzo Biochem, Inc. Announces Review of Strategic - GlobeNewswire
Enzo Biochem Announces Review Of Strategic Alternatives After Receiving Multiple Inquiries Regarding A Potential Transaction - marketscreener.com
Enzo Biochem, Inc. Announces Review of Strategic Alternatives after Receiving Multiple ... - Bluefield Daily Telegraph
Enzo Biochem Launches Strategic Review: Multiple Buyers Eye Global Life Sciences Operations - Stock Titan
Enzo Biochem transitions to OTCQX market By Investing.com - Investing.com South Africa
Enzo Biochem transitions to OTCQX market - Investing.com
OTC Markets Group welcomes addition of Enzo Biochem to OTCQX - Proactive Investors
OTC Markets Group Welcomes Enzo Biochem, Inc. to OTCQX | OTCM Stock News - GuruFocus
OTC Markets Group Welcomes Enzo Biochem, Inc. to OTCQX - The Manila Times
Enzo Biochem Makes Strategic Move to OTCQX Market: Cost Savings While Maintaining Investor Access - Stock Titan
The Zacks Analyst Blog AbbVie, The TJX, The Charles Schwab, Enzo Biochem and CVD Equipment - Yahoo Finance
Enzo Biochem (NYSE:ENZ) Now Covered by StockNews.com - Defense World
Market Resilience: Enzo Biochem, Inc (ENZ) Finishes Weak at 0.29, Down -8.98 - DWinneX
12 Health Care Stocks Moving In Wednesday's Pre-Market Session - Benzinga
Virtu Financial LLC Takes $35,000 Position in Enzo Biochem, Inc. (NYSE:ENZ) - Defense World
Enzo Biochem stock hits 52-week low at $0.33 amid market challenges By Investing.com - Investing.com South Africa
Enzo Biochem to Delist from NYSE, Move to OTCQX - TipRanks
Enzo Biochem stock hits 52-week low at $0.33 amid market challenges - Investing.com India
StockNews.com Begins Coverage on Enzo Biochem (NYSE:ENZ) - Defense World
Enzo Biochem to delist from NYSE, move to OTCQX market By Investing.com - Investing.com India
Enzo Biochem to voluntarily delist from NYSE and transfer trading of shares to OTCQX; shares fall - MSN
Enzo Biochem (ENZ) to Voluntarily Delist from NYSE, Move to OTCQ - GuruFocus
Enzo Biochem Announces Notification to New York Stock Exchange of Intention to Voluntarily Delist Common Stock and Transfer Trading of Shares to OTCQX - The Manila Times
Enzo Biochem to delist from NYSE, move to OTCQX market - Investing.com
Enzo Biochem Announces Notification to New York Stock - GlobeNewswire
Enzo Biochem Announces Notification to New York Stock Exchange of Intention to Voluntarily - Bluefield Daily Telegraph
NYSE Delisting Alert: Enzo Biochem Moving to OTCQXWhat Shareholders Must Know - Stock Titan
$7.5M Enzo Biochem data breach class action settlement - Class Action Lawsuits
Here’s Why Enzo Biochem (ENZ) Declined in Q4 - Yahoo Finance
ENZ Stock Down Following Q2 Earnings, Revenues Decline Y/Y - Nasdaq
Enzo Biochem Inc (ENZ) Reports Q2 Fiscal 2025 Revenue of $7.3 Mi - GuruFocus.com
Enzo Biochem: Fiscal Q2 Earnings Snapshot - The Pioneer
Enzo Biochem Reports Decline in Quarterly Revenues - TipRanks
Enzo Biochem Inc. ($0.01 Par Value) (ENZ) reports earnings - Quartz
Enzo Biochem Stages Comeback: Q2 Shows 18% Growth, Key Segment Returns to Profit - StockTitan
12 Health Care Stocks Moving In Monday's After-Market Session - Benzinga
Enzo Biochem: Fiscal Q2 Earnings Snapshot -March 17, 2025 at 04:30 pm EDT - Marketscreener.com
Finanzdaten der Enzo Biochem Inc-Aktie (ENZ)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.65%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):